Paper · 36804602
Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.
Stoffel EM and 2 others. Gastroenterology, 2023. Cited by 462 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Papers, record 36804602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36804602
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Early Detection of Cancer | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Risk Assessment | |
| Pancreas | |
| Risk Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA176828 | NCI NIH HHS | United States | R01CA176828 | PubMed and NIH | NIH RePORTER |
| U01 CA210170 | NCI NIH HHS | United States | U01CA210170 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06638866 | AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,485,131 | ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. | Am J Gastroenterol | 2018 | https://conductscience.org/library/papers/29485131 | PubMed |
| 2 | 30,946,242 | Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis. | Pancreas | 2019 | https://conductscience.org/library/papers/30946242 | PubMed |
| 3 | 35,166,713 | Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study. | Clin Transl Gastroenterol | 2022 | https://conductscience.org/library/papers/35166713 | PubMed |
| 4 | 36,316,508 | Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium. | Ann Surg Oncol | 2023 | https://conductscience.org/library/papers/36316508 | PubMed |
| 5 | 32,675,550 | Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer. | Ann Surg | 2020 | https://conductscience.org/library/papers/32675550 | PubMed |
| 6 | 35,333,778 | Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study. | Clin Transl Gastroenterol | 2022 | https://conductscience.org/library/papers/35333778 | PubMed |
| 7 | 30,721,664 | Early Detection of Pancreatic Cancer: Opportunities and Challenges. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30721664 | PubMed |
| 8 | 34,648,951 | Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer. | Clin Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/34648951 | PubMed |
| 9 | 32,213,015 | The diagnostic work-up and outcomes of 'presumed' idiopathic acute pancreatitis: A post-hoc analysis of a multicentre observational cohort. | United European Gastroenterol J | 2020 | https://conductscience.org/library/papers/32213015 | PubMed |
| 10 | 36,157,927 | International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis. | World J Gastroenterol | 2022 | https://conductscience.org/library/papers/36157927 | PubMed |
1 to 10 of 118
See all 118 referencesCited by343
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 462 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,967,213 | The Role and Mechanism of NCAPD2 In Regulating the P53 Signaling Pathway to Mediate the Proliferation and Invasion of Pancreatic Cancer Cells. | Rep Biochem Mol Biol | 2025 | https://conductscience.org/library/papers/42967213 | PubMed |
| 42,935,641 | Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935641 | PubMed |
| 42,928,513 | NCLX Inhibition plus Ca2+ Delivery Potentiates Electroporation and Antitumor Immunity in Pancreatic Ductal Adenocarcinoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42928513 | PubMed |
| 42,910,299 | HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42910299 | PubMed |
| 42,897,094 | Diabetes Among Finnish Pancreatic Cancer Patients: Prevalence, Time Interval Between Diabetes and Cancer Diagnosis, and Overall Survival. | Cancer Med | 2026 | https://conductscience.org/library/papers/42897094 | PubMed |
| 42,885,518 | Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells. | J Enzyme Inhib Med Chem | 2026 | https://conductscience.org/library/papers/42885518 | PubMed |
| 42,885,341 | Skeletal Muscle Index, Tumor and Systemic Immunity, and Survival in Advanced Pancreatic Ductal Adenocarcinoma. | Cancer Med | 2026 | https://conductscience.org/library/papers/42885341 | PubMed |
| 42,877,528 | Strategy for early diagnosis of pancreatic cancer. | Front Gastroenterol (Lausanne) | 2026 | https://conductscience.org/library/papers/42877528 | PubMed |
| 42,866,755 | Borderline resectable pancreatic ductal adenocarcinoma: a narrative review. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42866755 | PubMed |
| 42,856,819 | Development of a predictive model for pancreatic cancer integrating serum metabolomics and polygenic risk score. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42856819 | PubMed |
1 to 10 of 343
See all 343 cited byGenes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CPA1 | 1,357 | PubTator's text mining | https://conductscience.org/library/genes/1357 | NCBI Gene |
| CPB1 | 1,360 | PubTator's text mining | https://conductscience.org/library/genes/1360 | NCBI Gene |
| CTRC | 11,330 | PubTator's text mining | https://conductscience.org/library/genes/11330 | NCBI Gene |
| EPCAM | 4,072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| HGF | 3,082 | PubTator's text mining | https://conductscience.org/library/genes/3082 | NCBI Gene |
1 to 10 of 23
See all 23 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36804602
GET https://conductscience.org/api/papers/v1/36804602/references?page=2